Minamestane

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Minamestane
Minamestane.svg
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
Formula C19H23NO2
Molar mass 297.391 g/mol
3D model (JSmol)

Minamestane (INN (former developmental code name FCE-24,928) is a steroidal aromatase inhibitor which was under development by Farmitalia-Carlo Erba as an antineoplastic agent in the mid-1990s but was never marketed.[1][2][3]

Unlike other steroidal aromatase inhibitors such as formestane and exemestane, minamestane does not have androgenic properties.[2]

See also[edit]

References[edit]

  1. ^ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1357. ISBN 978-0-412-46630-4. Retrieved 20 May 2012. 
  2. ^ a b Di Salle E, Briatico G, Giudici D, et al. (June 1994). "Novel aromatase and 5 alpha-reductase inhibitors". The Journal of Steroid Biochemistry and Molecular Biology. 49 (4-6): 289–94. doi:10.1016/0960-0760(94)90270-4. PMID 8043491. 
  3. ^ Combs, Donald W (1995). "Review Oncologic, Endocrine & Metabolic: Recent developments in aromatase inhibitors". Expert Opinion on Therapeutic Patents. 5 (6): 529533. doi:10.1517/13543776.5.6.529. ISSN 1354-3776.